Citation Impact
Citing Papers
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Anaplasma phagocytophilum—a widespread multi-host pathogen with highly adaptive strategies
2013 Standout
Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
2010
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
2002 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Tick infestation (Acari: Ixodidae) in roe deer (Capreolus capreolus) from northwestern Spain: population dynamics and risk stratification
2010
Prevalence and outcomes of anemia in cancer: a systematic review of the literature
2004
Liposomes as nanomedical devices
2015 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy
1994
Febrile neutropenia: A critical review of the initial management
2010
Mitoxantrone
1996
Role of pegylated liposomal doxorubicin (Caelyx) in the treatment of relapsing ovarian cancer
2007
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Detection of Rickettsia africae in Rhipicephalus (Boophilus) decoloratus Ticks from the Republic of Botswana, South Africa
2007
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation
2006
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline
2013
Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer
2013
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
2006 Standout
Pegylated Liposomal Doxorubicin: Optimizing the Dosing Schedule in Ovarian Cancer
2005
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
What treatment for elderly patients with aggressive lymphoma?
1994
Works of André Uys being referenced
Mitoxantrone in the Treatment of Acute Leukemia
1990
A survey of free-living ixodid ticks on a commercial game farm in the Thabazimbi District, Limpopo Province, South Africa
2006
Recombinant Human Erythropoietin in the Treatment of Cancer-Related Anaemia
1994
Ticks associated with the three largest wild ruminant species in Southern Africa
2007
Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10
2007
Chronological age is a multifactorial prognostic variable in patients with Non-Hodgkin’s Lymphoma
1992
179 A phase II second line study of liposomal doxorubicin and carboplatin in patients with recurrent ovarian cancer with a disease free interval equal or greater than 6 months
2003
Phase 2 study of combination therapy with liposomal doxorubicin and carboplatin in patients with relapsed, platinum sensitive ovarian cancer
2004
Phase 2 study of combination therapy with liposomal doxorubicin and carboplatin in patients with relapsed, platinum sensitive ovarian cancer
2004